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Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare but important
cause of stroke-like symptoms which can often be missed Thambisetty and Newman 2004. We describe a case of a young male
presenting with stroke-like episodes, later diagnosed with MELAS in an attempt to improve the understanding about diagnosing
MELAS in the appropriate clinical context.
1.CaseSummary
A 34 year-old black male with no signiﬁcant past medical
history presented with new-onset migraine like headaches
and blurry vision. He was ruled out for subarachnoid hem-
orrhagewithaheadCTandlumbarpunctureanddischarged
home from the emergency room with analgesics.
Hepresentedagain,after2months,withleftlegweakness
and painful cramps. He was found to have left hemiparesis,
with spasticity and frequent myoclonic jerks. CT and MR
imaging revealed acute right posterior para-sagital temporo-
parietal ischemic strokes (Figure 1). The rest of the physical
exam was normal. His initial blood work (complete blood
count, chemistry, coagulation studies) were unremarkable.
Further work-up excluded atherosclerosis, hypercoagulable
disorders, potential embolic sources, connective tissue and
inﬂammatory or autoimmune disorders. He was soon dis-
charged to a rehabilitation facility and from there to home,
with excellent functional improvement.
The patient was re-admitted one month later for sudden
onset loss of vision. Physical examination revealed a right
homonymous hemianopsia; by that time, his aforemen-
tioned left leg hemiparesis was remarkably improved. Neu-
roimaging on this admission revealed new hypodensities in
the left parietal and occipital lobes and near resolution of
cerebral lesions noted on his previous admission (Figure 2).
The combination of migraine like headaches, visual
complaints, painful myoclonic jerks and rapidly resolving
strokes of non-vascular distribution in the posterior areas
raised the clinical suspicion of MELAS syndrome. Additional
testing revealed a serum lactate of 3.06mmol/L (normal:
0.3–1.3mmol/L), CSF lactate of 4.6mmol/L (normal: 1.1–
2.8mmol/L) and CSF pyruvate of 3.5mmol/L (Normal:
0.5–1.7mmol/L). Genetic testing conﬁrmed the presence
of the A-to-G point mutation at the 3243 position in the
mitochondrial DNA, which is diagnostic for MELAS [1].
2. Discussion
MELAS syndrome is a rare neurodegenerative disease caused
by the decreased ability of cells to produce suﬃcient energy
in the form of adenosine 5-triphosphate [2]. Although it
is one of the most common maternally inherited mito-
chondrial disorders, its exact incidence is unknown [2].
Early development is usually normal and the ﬁrst symptoms
are noted in childhood or early adolescence [3], but the
syndrome can present for the ﬁrst time in older individuals,
as demonstrated in the present case.2 Stroke Research and Treatment
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Figure 1: Visit 2 (09/2010) Coronal Flair MRI Image showing acute
right para-sagital posterior temporo-parietal ischemic stroke.
Figure 2: Visit 3 (10/2010) Coronal Flair MRI Image showing
hypodensities in the left parietal and occipital lobes and near
resolution of cerebral lesions noted on visit 2.
At least 40 distinct mitochondrial DNA mutations have
been associated with MELAS; about 80% of MELAS patients
have an A3243G mutation in the mitochondrial tRNA gene
[3]. Exact pathogenesis of the stroke-like episodes remains
uncertain, although mitochondrial angiopathy, mitochon-
drial cytopathy and non-ischemic neurovascular cellular
mechanisms have all been suggested [2].
Approximately 80% of patients with MELAS have symp-
tom onset between the ages of 5 and 15 years. MELAS
syndrome has been less frequently described in blacks and
the presentation of our patient, except his age and race, was
otherwise typical of the syndrome, which is characterized
by stroke-like episodes in the parieto-temporal and occipital
areas, opthalmoplegia and visual complaints, as well as
migraine-type headaches and painful cramps [2, 3]. Young
patients with MELAS can also present with tonic-clonic
seizures, hearing loss, as well as autism-like and other
psychiatric disorders [2, 3].
In addition to its neurologic manifestations, MELAS
syndrome may also exhibit multisystem eﬀects including
cardiac conduction defects, diabetes mellitus, short stature,
myopathy, and gastrointestinal disturbances [1, 2]. No stan-
dard therapies exist for this syndrome but many believe in
using l-arginine, coenzyme-Q, B-vitamins, and levocarnitine
aiming to minimize the demands on the mitochondria,
hence supporting and maximizing their function [1, 2, 4].
In conclusion, this case underscores the importance of
including MELAS in the diﬀerential diagnosis of stroke
in young male adults, speciﬁcally those presenting with
ischemic-like strokes in the posterior cerebral areas and with
a history of non-speciﬁc and easily overlooked symptoms,
like recurring headaches, muscle cramps and episodes of
blurry vision.
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